Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

Topic

All

21

Aug

2017

Scott Gottlieb’s First 100 Days at the FDA: A Timeline

/

/

/

All, Politics, The Edge

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

18

Aug

2017

Industry Leadership Tests, Pfizer and AZ Win Cancer Drug Approvals, Unity Reloads

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

17

Aug

2017

We Can Follow Through On Our Own After Charlottesville

/

/

/

All, People, Politics

[Editor’s Note: Steve Graham of Fenwick & West is one of biotech’s leading corporate attorneys with 40 years of experience. His book, “Invisible Ink: Navigating racism in corporate America” was published in April.] I spent my first few years of elementary school in segregated schools. Beaches were segregated. The drinking fountains and restrooms were labeled. At movie theatres, colored people were...

16

Aug

2017

At What Price a Seat at the Table?

/

Steve Holtzman & Jeremy Levin

/

/

[Editor’s Note: This editorial was co-authored by Steve Holtzman, CEO of Decibel Therapeutics, and Jeremy Levin, CEO of Ovid Therapeutics in the aftermath of violent clashes between white supremacists and counter-protesters in Charlottesville, Virginia.] FACT 1: The overwhelming majority of the men and women in the biopharmaceutical industry, scientists and non-scientists alike, have been drawn to their profession by the noble...

14

Aug

2017

How Do You Manage Biotech Information to Think Widely and Deeply?

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

11

Aug

2017

Grail Plucks Low-Hanging Fruit, eGenesis Creates PERV-Free Pigs, & Roivant Raises $1B

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

31

Jul

2017

Whither Experts? A Review of The Death of Expertise and Some Thoughts for Biopharma

/

/

/

All, People, Politics

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

24

Jul

2017

How Agios, Neurocrine Are Striving to Go Commercial, and Hold Onto Their Souls

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

21

Jul

2017

Vertex’s Grand Slam for CF, Puma Stretches on Price, Sarepta & BioMarin Bury the Hatchet

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

19

Jul

2017

Family Offices: Quietly Putting Money to Work in Biotech Startups

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

14

Jul

2017

Novartis’ Big CAR-T Moment, Amicus Exits FDA Penalty Box, and Evelo’s Bold $50M Microbiome Play

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

11

Jul

2017

A One-Bug Drug For the Immune System? Evelo Gets $50M to Test Concept

/

/

/

All, Cancer, Venture Capital

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

10

Jul

2017

Allergan’s Social Contract, One Year Later: CEO Brent Saunders Reflects on the Expected and Unexpected

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

7

Jul

2017

Konica’s Precision Medicine Power Play, Endo Yanks Opioid, Celgene’s PD-1 Foray

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

5

Jul

2017

So You Think Your Drug Could Be Best-in-Class? What If the World Changes?

/

Nagesh Mahanthappa

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

30

Jun

2017

Merck’s CV Surprise, FDA Clamors for Generics and Amgen & Illumina’s Precision Medicine Win

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

29

Jun

2017

How to Find Biotech Startup Cash, With or Without Traditional VCs

/

/

/

All, Venture Capital

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

26

Jun

2017

Watershed Moments: When Celgene and Bristol-Myers Squibb Became Deal Winners

/

/

/

All, People, The Edge

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

23

Jun

2017

Senate Healthcare Overhaul Advances, Novartis Nails CV Study, Clovis Cashes In on PARP Win

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

22

Jun

2017

Repare Secures $68M Series A to Discover ‘Synthetic Lethal’ Cancer Drugs

/

/

/

All, Cancer, Venture Capital

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

1 2 3 … 18 Next ›